8-K: Xenetic Biosciences Changes Accounting Firms Following Acquisition
8-K Filing
Xenetic Biosciences replaces Marcum LLP with CBIZ CPAs P.C. as its independent registered public accounting firm following Marcum's acquisition by CBIZ.
Summary
- Xenetic Biosciences announced that Marcum LLP resigned as their independent registered public accounting firm on April 8, 2025, due to CBIZ CPAs P.C.'s acquisition of Marcum's attest business.
- The company's Audit Committee approved Marcum's resignation.
- Marcum's audit reports for the fiscal years ended December 31, 2024 and 2023 did not contain any adverse opinions, disclaimers, qualifications, or modifications.
- There were no disagreements or reportable events between Xenetic Biosciences and Marcum during the relevant periods.
- On April 9, 2025, Xenetic Biosciences engaged CBIZ as their new independent registered public accounting firm for the fiscal year ending December 31, 2025, with the approval of the Audit Committee.
- The company did not consult with CBIZ on accounting principles or audit opinions prior to the engagement.
Sentiment
Score: 7
Explanation: The announcement is neutral, reflecting a standard administrative change due to an acquisition. There are no indications of financial distress or irregularities.
Positives
- Marcum's audit reports for 2023 and 2024 were clean, with no adverse opinions or qualifications.
- There were no disagreements or reportable events between Xenetic Biosciences and Marcum during the relevant periods.
- The transition to a new accounting firm appears to be smooth, with no reported issues or concerns.
Industry Context
Changes in accounting firms are not uncommon, especially following mergers and acquisitions within the accounting industry. Companies routinely update their filings to reflect these changes, ensuring compliance with SEC regulations.
Stakeholder Impact
- Shareholders may be interested in the change of accounting firms, but the impact is likely minimal as long as the transition is smooth and the new firm is qualified.
- Employees within the finance department may experience some adjustments during the transition.
Key Dates
| Date | Description |
|---|---|
| November 1, 2024 | CBIZ CPAs P.C. acquired the attest business of Marcum LLP. |
| April 8, 2025 | Marcum LLP resigned as Xenetic Biosciences' independent registered public accounting firm. |
| April 8, 2025 | Marcum LLP provided a letter agreeing with the statements made by Xenetic Biosciences in the Form 8-K. |
| April 9, 2025 | CBIZ CPAs P.C. was engaged as Xenetic Biosciences' new independent registered public accounting firm. |
| April 10, 2025 | Date of report signed by James Parslow, Interim Chief Executive Officer & Chief Financial Officer. |
| December 31, 2025 | Fiscal year end for which CBIZ is engaged as the independent registered public accounting firm. |
Keywords
accounting firm, CBIZ, Marcum LLP, independent auditor, audit committee, resignation, engagement, financial statements, Xenetic Biosciences
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.